Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity.
Flavahan
N A
NA
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. 21205.
D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D019204:GTP-Binding Proteins / Q000502:physiology; D006801:Humans; D008074:Lipoproteins / Q000502:physiology*; D009569:Nitric Oxide / Q000378:metabolism*; D015398:Signal Transduction; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D008074:Lipoproteins; D010566:Virulence Factors, Bordetella; D009569:Nitric Oxide; D019204:GTP-Binding Proteins